Combination drug therapy beats solo treatment for aggressive prostate cancer relapse

Combining testosterone-blocking drugs in patients with prostate cancer relapse prevents the spread of cancer better than treatment with a single drug, a multi-institution, Phase 3 clinical trial led by UC San Francisco researchers has found.

NYC Health Chief Aims to Redefine Public Health Post-COVID

Public health has endured a very public critique during the acute crisis of the COVID-19 pandemic and its aftermath. Now, public health leaders are tasked

August 23, 2023

Study identifies two stem cell types driving jellyfish tentacle growth

At about the size of a pinkie nail, the jellyfish species Cladonema can regenerate an amputated tentacle in two to three days -; but how?

December 26, 2023

IGC Pharma obtains funds to boost Alzheimer’s research

The company’s IGC-AD1 is being evaluated in a Phase II trial to treat agitation in patients with Alzheimer’s associated dementia. Credit: Giovanni Cancemi via Shutterstock.com.

July 10, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.